Revisiting bioceramics: Bone regenerative and local drug delivery systems

Progress in Solid State Chemistry

Volumn 40, Issue 3, 2012, Pages 17-30

  Manzano, Miguel ^a   Vallet Regi M ^b  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

Author keywords

Bioceramics; Bone regeneration; Drug delivery

Indexed keywords

BONE; DRUG DELIVERY; MEDICAL APPLICATIONS; NANOPARTICLES; SCAFFOLDS (BIOLOGY); TISSUE ENGINEERING;

BIOMEDICAL APPLICATIONS; BONE REGENERATION; BONE TISSUE ENGINEERING; DRUG DELIVERY SYSTEM; LOCAL DRUG DELIVERY; MESOPOROUS SILICA NANOPARTICLES;

BIOCERAMICS;

EID: 84869082598     PISSN: 00796786     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.progsolidstchem.2012.05.001     Document Type: Review

References (147)

1. Vallet-Regi M, Balas F, Colilla M, Manzano M. Bone-regenerative bioceramic implants with drug and protein controlled delivery capability. Progress in Solid State Chemistry 2008;36:163-91.
2. Juhasz JA, Best SM. Bioactive ceramics: processing, structures and properties. Journal of Materials Science 2012;47:610-24.
3. Vallet-Regi M, Arcos D. Chapter 1 biological apatites in bone and teeth. Biomimetic nanoceramics in clinical use: from materials to applications. The Royal Society of Chemistry 2008:1-24.
4. Mistry AS, Mikos AG. Tissue engineering strategies for bone regeneration. In: Yannas IV, editor. Regenerative medicine Ii: clinical and preclinical applications; 2005. p. 1-22. (Pubitemid 44608653)
5. Hench LL, Polak JM. Third-generation biomedical materials. Science 2002; 295. 1014-+.
6. Vallet-Regí M, Manzano M. Hierarchically structured porous materialseapplications in biochemistry: bioceramics, life science, and drug delivery. Hierarchically Structured porous materials. Wiley-VCH Verlag GmbH & Co. KGaA; 2011. 601-620.
7. Lopez-Noriega A, Arcos D, Izquierdo-Barba I, Sakamoto Y, Terasaki O, Vallet-Regi M. Ordered mesoporous bioactive glasses for bone tissue regeneration. Chemistry of Materials 2006;18:3137-44. (Pubitemid 44116093)
8. Yan XX, Yu CZ, Zhou XF, Tang JW, Zhao DY. Highly ordered mesoporous bioactive glasses with superior in vitro bone-forming bioactivities. Angewandte Chemie International Edition 2004;43:5980-4.
9. Izquierdo B, Arcos D, Sakamoto Y, Terasaki O, Lopez-Noriega A, Vallet-Regi M. High-performance mesoporous bioceramics mimicking bone mineralization. Chemistry of Materials 2008;20:3191-8. (Pubitemid 351744611)
10. Vallet-Regi M. Ordered mesoporous materials in the context of drug delivery systems and bone tissue engineering. Chemistry-A European Journal 2006; 12:5934-43. (Pubitemid 44231020)
11. Izquierdo-Barba I, Manzano M, Colilla M, Vallet-Regi M. Silica-based ordered mesoporous materials for biomedical applications. Key Engineering Materials 2008;377:133-50. (Pubitemid 351702021)
12. Vallet-Regi M. Nanostructured mesoporous silica matrices in nanomedicine. Journal of Internal Medicine 2010;267:22-43.
13. Vallet-Regi M, Ruiz-Gonzalez L, Izquierdo-Barba I, Gonzalez-Calbet JM. Revisiting silica based ordered mesoporous materials: medical applications. Journal of Materials Chemistry 2006;16:26-31. (Pubitemid 43324482)
14. Lozano D, Manzano M, Doadrio JC, Salinas AJ, Vallet-Regi M, Gomez-Barrena E, et al. Osteostatin-loaded bioceramics stimulate osteoblastic growth and differentiation. Acta Biomaterialia 2010;6:797-803.
15. Trejo CG, Lozano D, Manzano M, Doadrio JC, Salinas AJ, Dapia S, et al. The osteoinductive properties of mesoporous silicate coated with osteostatin in a rabbit femur cavity defect model. Biomaterials 2010;31:8564-73.
16. Hoffmann F, Cornelius M, Morell J, Froba M. Silica-based mesoporous organic-inorganic hybrid materials. Angewandte Chemie International Edition 2006;45:3216-51. (Pubitemid 44098982)
17. Colilla M, Izquierdo-Barba I, Sanchez-Salcedo S, Fierro JLG, Hueso JL, Vallet-Regi M. Synthesis and characterization of zwitterionic SBA-15 nano-structured materials. Chemistry of Materials 2010;22:6459-66.
18. Izquierdo-Barba I, Sanchez-Salcedo S, Colilla M, Feito MJ, Ramirez-Santillan C, Portoles MT, et al. Inhibition of bacterial adhesion on biocompatible zwitterionic SBA-15 mesoporous materials. Acta Biomaterialia 2011; 7:2977-85.
19. Kinnari TJ, Esteban J, Gomez-Barrena E, Zamora N, Fernandez-Roblas R, Nieto A, et al. Bacterial adherence to SiO(2)-based multifunctional bio-ceramics. Journal of Biomedical Materials Research Part A 2009;89A: 215-23.
20. Langer R, Vacanti JP. Tissue engineering. Science 1993;260:920-6. (Pubitemid 23209960)
21. Vallet-Regi M, Ruiz-Hernandez E. Bioceramics: from bone regeneration to cancer nanomedicine. Advanced Materials 2011;23:5177-218.
22. O'Brien FJ. Biomaterials & scaffolds for tissue engineering. Mater Today 2011; 14:88-95.
23. Langer R. Biomaterials in drug delivery and tissue engineering: one laboratory's experience. Accounts of Chemical Research 2000;33:94-101.
24. Porter JR, Ruckh TT, Popat KC. Bone tissue engineering: a review in bone biomimetics and drug delivery strategies. Biotechnology Progress 2009;25: 1539-60.
25. Lu JX, Flautre B, Anselme K, Hardouin P, Gallur A, Descamps M, et al. Role of interconnections in porous bioceramics on bone recolonization in vitro and in vivo. Journal of Materials Science-Materials in Medicine 1999;10: 111-20. (Pubitemid 29097627)
26. Chu TMG, Orton DG, Hollister SJ, Feinberg SE, Halloran JW. Mechanical and in vivo performance of hydroxyapatite implants with controlled architectures. Biomaterials 2002;23:1283-93. (Pubitemid 34112425)
27. Karageorgiou V, Kaplan D. Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials 2005;26:5474-91. (Pubitemid 40592136)
28. Oliveira JM, Costa SA, Leonor IB, Malafaya PB, Mano JF, Reis RL. Novel hydroxyapatite/carboxymethylchitosan composite scaffolds prepared through an innovative "autocatalytic" electroless coprecipitation route. Journal of Biomedical Materials Research Part A 2009;88A:470-80.
29. Charles-Harris M, del Valle S, Hentges E, Bleuet P, Lacroix D, Planell JA. Mechanical and structural characterisation of completely degradable polylactic acid/calcium phosphate glass scaffolds. Biomaterials 2007;28: 4429-38. (Pubitemid 47212416)
30. Kim SS, Park MS, Jeon O, Choi CY, Kim BS. Poly(lactide-co-glycolide)/ hydroxyapatite composite scaffolds for bone tissue engineering. Biomaterials 2006;27:1399-409. (Pubitemid 41739565)
31. Fabbri M, Celotti GC, Ravaglioli A. Hydroxyapatite-based porous aggregates: physico-chemical nature, structure, texture and architecture. Biomaterials 1995;16:225-8.
32. Leong KF, Cheah CM, Chua CK. Solid freeform fabrication of three-dimensional scaffolds for engineering replacement tissues and organs. Biomaterials 2003;24:2363-78. (Pubitemid 36434056)
33. Peltola SM, Melchels FPW, Grijpma DW, Kellomaki M. A review of rapid prototyping techniques for tissue engineering purposes. Annals of Medicine 2008;40:268-80. (Pubitemid 351563939)
34. Shin H, Jo S, Mikos AG. Biomimetic materials for tissue engineering. Biomaterials 2003;24:4353-64. (Pubitemid 36960133)
35. Manzano M, Lozano D, Arcos D, Portal-Nunez S, la Orden CL, Esbrit P, et al. Comparison of the osteoblastic activity conferred on Si-doped hydroxyapatite scaffolds by different osteostatin coatings. Acta Biomaterialia 2011;7: 3555-62.
36. Yun HS, Kim SE, Hyeon YT. Design and preparation of bioactive glasses with hierarchical pore networks. Chemical Communications 2007:2139-41.
37. Yun HS, Kim SE, Hyun YT, Heo SJ, Shin JW. Three-dimensional mesoporous-giantporous inorganic/organic composite scaffolds for tissue engineering. Chemistry of Materials 2007;19:6363-6.
38. Li X, Wang XP, Chen HR, Jiang P, Dong XP, Shi JL. Hierarchically porous bioactive glass scaffolds synthesized with a PUF and P123 cotemplated approach. Chemistry of Materials 2007;19:4322-6. (Pubitemid 47340307)
39. Zhu YF, Wu CT, Ramaswamy Y, Kockrick E, Simon P, Kaskel S, et al. Preparation, characterization and in vitro bioactivity of mesoporous bioactive glasses (MBGs) scaffolds for bone tissue engineering. Microporous and Mesoporous Materials 2008;112:494-503. (Pubitemid 351657477)
40. Yun HS, Kim SE, Hyun YT. Fabrication of hierarchically porous bioactive glass ceramics. In: Daculsi G, Layrolle P, editors. Bioceramics, vol. 20. Stafa-Zurich: Trans Tech Publications Ltd; 2008. p. 285-8. Pts 1 and 2.
41. Yun HS, Kim SE, Hyun YT, Heo SJ, Shin JW. Hierarchically mesoporous-macroporous bioactive glasses scaffolds for bone tissue regeneration. Journal of Biomedical Materials Research Part B 2008;87B:374-80.
42. Li X, Shi J, Dong X, Zhang L, Zeng H. A mesoporous bioactive glass/polycaprolactone composite scaffold and its bioactivity behavior. Journal of Biomedical Materials Research Part A 2008;84A:84-91. (Pubitemid 350244249)
43. Yun HS, Kim SE, Hyun YT. Preparation of bioactive glass ceramic beads with hierarchical pore structure using polymer self-assembly technique. Materials Chemistry and Physics 2009;115:670-6.
44. Yun HS, Kim SE, Park EK. Bioactive glass-poly (epsilon-caprolactone) composite scaffolds with 3 dimensionally hierarchical pore networks. Materials Science and Engineering C: Materials for Biological Application 2011;31:198-205.
45. Rezwan K, Chen QZ, Blaker JJ, Boccaccini AR. Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. Biomaterials 2006;27:3413-31.
46. Garcia A, Colilla M, Izquierdo-Barba I, Vallet-Regi M. Incorporation of phosphorus into mesostructured silicas: a novel approach to reduce the SiO(2) leaching in water. Chemistry of Materials 2009;21:4135-45.
47. Garcia A, Izquierdo-Barba I, Colilla M, de Laorden CL, Vallet-Regi M. Preparation of 3-D scaffolds in the SiO(2)-P(2)O(5) system with tailored hierarchical meso-macroporosity. Acta Biomaterialia 2011;7:1265-73.
48. Assaker R. Minimal access spinal technologies: state-of-the-art, indications, and techniques. Joint Bone Spine 2004;71:459-69. (Pubitemid 39626711)
49. Temenoff JS, Mikos AG. Injectable biodegradable materials for orthopedic tissue engineering. Biomaterials 2000;21:2405-12.
50. Montufar EB, Traykova T, Gil C, Harr I, Almirall A, Aguirre A, et al. Foamed surfactant solution as a template for self-setting injectable hydroxyapatite scaffolds for bone regeneration. Acta Biomaterialia 2010; 6:876-85.
51. Kim H-W, Knowles JC, Kim H-E. Hydroxyapatite/poly(-caprolactone) composite coatings on hydroxyapatite porous bone scaffold for drug delivery. Biomaterials 2004;25:1279-87. (Pubitemid 37476205)
52. Cicuéndez M, Izquierdo-Barba I, Sánchez-Salcedo S, Vila M, Vallet-Regí M. Biological performance of hydroxyapatiteebiopolymer foams: in vitro cell response. Acta Biomaterialia 2012;8:802-10.
53. Sanchez-Salcedo S, Vila M, Izquierdo-Barba I, Cicuendez M, Vallet-Regi M. Biopolymer-coated hydroxyapatite foams: a new antidote for heavy metal intoxication. Journal of Materials Chemistry 2010;20:6956-61.
54. Vila M, Sanchez-Salcedo S, Cicuendez M, Izquierdo-Barba I, Vallet-Regi M. Novel biopolymer-coated hydroxyapatite foams for removing heavymetals from polluted water. Journal of Hazardous Materials 2011;192: 71-7.
55. Habraken W, Wolke JGC, Jansen JA. Ceramic composites as matrices and scaffolds for drug delivery in tissue engineering. Advanced Drug Delivery Reviews 2007;59:234-48. (Pubitemid 46879968)
56. Mourino V, Boccaccini AR. Bone tissue engineering therapeutics: controlled drug delivery in three-dimensional scaffolds. Journal of the Royal Society, Interface 2010;7:209-27.
57. Zhu YF, Kaskel S. Comparison of the in vitro bioactivity and drug release property of mesoporous bioactive glasses (MBGs) and bioactive glasses (BGs) scaffolds. Microporous and Mesoporous Materials 2009;118:176-82.
58. Vallet-Regi M, Balas F, Colilla M, Manzano M. Bioceramics and pharmaceuticals: a remarkable synergy. Solid State Sciences 2007;9:768-76. (Pubitemid 47446354)
59. Vallet-Regi M, Balas F, Arcos D. Mesoporous materials for drug delivery. Angewandte Chemie International Edition 2007;46:7548-58. (Pubitemid 47556998)
60. Manzano M, Colilla M, Vallet-Regi M. Drug delivery from ordered mesoporous matrices. Expert Opinion on Drug Delivery 2009;6:1383-400.
61. Manzano M, Vallet-Regi M. New developments in ordered mesoporous materials for drug delivery. Journal of Materials Chemistry 2010;20: 5593-604.
62. Ferrari M. Cancer nanotechnology: opportunities and challenges. Nature Reviews Cancer 2005;5:161-71. (Pubitemid 40314948)
63. Duncan R, Gaspar R. Nanomedicine(s) under the microscope. Molecular Pharmaceutics 2011;8:2101-41.
64. Minelli C, Lowe SB, Stevens MM. Engineering Nanocomposite materials for cancer therapy. Small 2010;6:2336-57.
65. Singh N, Karambelkar A, Gu L, Lin K, Miller JS, Chen CS, et al. Bioresponsive mesoporous silica nanoparticles for triggered drug release. Journal of the American Chemical Society 2011;133:19582-5.
66. Garcia-Bennett AE. Synthesis, toxicology and potential of ordered mesoporous materials in nanomedicine. Nanomedicine 2011;6:867-77.
67. Martin KR. The chemistry of silica and its potential health benefits. Journal of Nutrition, Health & Aging 2007;11:94-8. (Pubitemid 46729217)
68. Kohane DS, Langer R. Biocompatibility and drug delivery systems. Chemical Science 2010;1:441-6.
69. Vivero-Escoto JL, Slowing II, Trewyn BG, Lin VSY. Mesoporous silica nano-particles for intracellular controlled drug delivery. Small 2010;6:1952-67.
70. Lin YS, Tsai CP, Huang HY, Kuo CT, Hung Y, Huang DM, et al. Well-ordered mesoporous silica nanoparticles as cell markers. Chemistry of Materials 2005;17:4570-3. (Pubitemid 41362484)
71. Slowing II, Trewyn BG, Lin VSY. Mesoporous silica nanoparticles for intra-cellular delivery of membrane-impermeable proteins. Journal of the American Chemical Society 2007;129:8845-9. (Pubitemid 47492073)
72. Slowing I, Trewyn BG, Lin VSY. Effect of surface functionalization of MCM-41-type mesoporous silica nanoparticleson the endocytosis by human cancer cells. Journal of the American Chemical Society 2006;128: 14792-3. (Pubitemid 44851603)
73. Radu DR, Lai CY, Jeftinija K, Rowe EW, Jeftinija S, Lin VSY. A polyamidoamine dendrimer-capped mesoporous silica nanosphere-based gene transfection reagent. Journal of the American Chemical Society 2004;126:13216-7. (Pubitemid 39382736)
74. Giri S, Trewyn BG, Stellmaker MP, Lin VSY. Stimuli-responsive controlled-release delivery system based on mesoporous silica nanorods capped with magnetic nanoparticles. Angewandte Chemie International Edition 2005;44: 5038-44. (Pubitemid 41188539)
75. Lu F, Wu SH, Hung Y, Mou CY. Size effect on cell uptake in well-Suspended, uniform mesoporous silica nanoparticles. Small 2009;5:1408-13.
76. Lu J, Liong M, Zink JI, Tamanoi F. Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs. Small 2007;3:1341-6. (Pubitemid 47245524)
77. Yu T, Malugin A, Ghandehari H. Impact of silica nanoparticle design on cellular toxicity and hemolytic activity. ACS Nano 2011;5:5717-28.
78. Lai CY, Trewyn BG, Jeftinija DM, Jeftinija K, Xu S, Jeftinija S, et al. A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules. Journal of the American Chemical Society 2003;125:4451-9. (Pubitemid 36418692)
79. Witasp E, Kupferschmidt N, Bengtsson L, Hultenby K, Smedman C, Paulie S, et al. Efficient internalization of mesoporous silica particles of different sizes by primary human macrophages without impairment of macrophage clearance of apoptotic or antibody-opsonized target cells. Toxicology and Applied Pharmacology 2009;239:306-19.
80. Chung TH, Wu SH, Yao M, Lu CW, Lin YS, Hung Y, et al. The effect of surface charge on the uptake and biological function of mesoporous silica nano-particles 3T3-L1 cells and human mesenchymal stem cells. Biomaterials 2007;28:2959-66. (Pubitemid 46560868)
81. Huang D-M, Hung Y, Ko B-S, Hsu S-C, Chen W-H, Chien C-L, et al. Highly efficient cellular labeling of mesoporous nanoparticles in human mesenchymal stem cells: implication for stem cell tracking. The FASEB Journal 2005;19:2014-6. (Pubitemid 41759749)
82. Vallhov H, Gabrielsson S, Stromme M, Scheynius A, Garcia-Bennett AE. Mesoporous silica particles induce size dependent effects on human dendritic cells. Nano Letters 2007;7:3576-82.
83. Tao ZM, Morrow MP, Asefa T, Sharma KK, Duncan C, Anan A, et al. Mesoporous silica nanoparticles inhibit cellular respiration. Nano Letters 2008;8: 1517-26.
84. Slowing II, Wu CW, Vivero-Escoto JL, Lin VSY. Mesoporous silica nano-particles for reducing Hemolytic activity towards mammalian red blood cells. Small 2009;5:57-62.
85. Lin YS, Haynes CL. Impacts of mesoporous silica nanoparticle size, pore ordering, and pore integrity on Hemolytic activity. Journal of the American Chemical Society 2010;132:4834-42.
86. Slowing II, Vivero-Escoto JL, Wu CW, Lin VSY. Mesoporous silica nano-particles as controlled release drug delivery and gene transfection carriers. Advanced Drug Delivery Reviews 2008;60:1278-88.
87. Lopez T, Basaldella EI, Ojeda ML, Manjarrez J, Alexander-Katz R. Encapsulation of valproic acid and sodic phenytoin in ordered mesoporous SiO2 solids for the treatment of temporal lobe epilepsy. Optical Materials 2006;29:75-81. (Pubitemid 44389906)
88. Wu S-H, Lin Y-S, Hung Y, Chou Y-H, Hsu Y-H, Chang C, et al. Multifunctional mesoporous silica nanoparticles for intracellular labeling and animal magnetic resonance imaging studies. ChemBioChem 2008;9:53-7.
89. Lu J, Liong M, Li ZX, Zink JI, Tamanoi F. Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals. Small 2010;6:1794-805.
90. Liu HM, Wu SH, Lu CW, Yao M, Hsiao JK, Hung Y, et al. Mesoporous silica nanoparticles improve magnetic labeling efficiency in human stem cells. Small 2008;4:619-26. (Pubitemid 351808060)
91. Hsiao JK, Tsai CP, Chung TH, Hung Y, Yao M, Liu HM, et al. Mesoporous silica nanoparticles as a delivery system of gadolinium for effective human stem cell tracking. Small 2008;4:1445-52.
92. Kim J, Kim HS, Lee N, Kim T, Kim H, Yu T, et al. Multifunctional uniform nanoparticles composed of a magnetite nanocrystal core and a mesoporous silica shell for magnetic resonance and fluorescence imaging and for drug delivery. Angewandte Chemie International Edition 2008;47:8438-41.
93. Taylor KML, Kim JS, Rieter WJ, An H, Lin WL, Lin WB. Mesoporous silica nanospheres as highly efficient MRI contrast agents. Journal of the American Chemical Society 2008;130. 2154-+.
94. Hudson SP, Padera RF, Langer R, Kohane DS. The biocompatibility of mesoporous silicates. Biomaterials 2008;29:4045-55.
95. Vallet-Regi M, Ramila A, del Real RP, Perez-Pariente J. A new property of MCM-41: drug delivery system. Chemistry of Materials 2001;13:308-11. (Pubitemid 32199334)
96. Schlossbauer A, Warncke S, Gramlich PME, Kecht J, Manetto A, Carell T, et al. A programmable DNA-based molecular valve for colloidal mesoporous silica. Angewandte Chemie International Edition 2010;49:4734-7.
97. You YZ, Kalebaila KK, Brock SL, Oupicky D. Temperature-controlled uptake and release in PNIPAM-modified porous silica nanoparticles. Chemistry of Materials 2008;20:3354-9.
98. Chang JH, Shim CH, Kim BJ, Shin Y, Exarhos GJ, Kim KJ. Bicontinuous, thermoresponsive, L-3-phase silica nanocomposites and their smart drug-delivery applications. Advanced Materials 2005;17. 634-+.
99. Fu Q, Rao GVR, Ista LK, Wu Y, Andrzejewski BP, Sklar LA, et al. Control of molecular transport through stimuli-responsive ordered mesoporous materials. Advanced Materials 2003;15. 1262-+.
100. Zhou ZY, Zhu SM, Zhang D. Grafting of thermo-responsive polymer inside mesoporous silica with large pore size using ATRP and investigation of its use in drug release. Journal of Materials Chemistry 2007;17:2428-33. (Pubitemid 46884070)
101. Meng HA, Xue M, Xia TA, Zhao YL, Tamanoi F, Stoddart JF, et al. Autonomous in vitro anticancer drug release from mesoporous silica nanoparticles by pH-Sensitive Nanovalves. Journal of the American Chemical Society 2010;132: 12690-7.
102. Liu R, Zhang Y, Zhao X, Agarwal A, Mueller LJ, Feng PY. pH-responsive nanogated ensemble based on gold-capped mesoporous silica through an acid-labile acetal linker. Journal of the American Chemical Society 2010;132. 1500-+.
103. Park C, Oh K, Lee SC, Kim C. Controlled release of guest molecules from mesoporous silica particles based on a pH-responsive polypseudorotaxane motif. Angewandte Chemie International Edition 2007;46:1455-7. (Pubitemid 46959995)
104. Karen A, Fisher KDHMJT. Comparison of micro- and mesoporous inorganic materials in the uptake and release of the drug model fluorescein and its analogues. Chemistry A European Journal 2003;9:5873-8.
105. Yang Q, Wang SH, Fan PW, Wang LF, Di Y, Lin KF, et al. pH-responsive carrier system based on carboxylic acid modified mesoporous silica and polyelectrolyte for drug delivery. Chemistry of Materials 2005;17:5999-6003. (Pubitemid 41784404)
106. Leung KCF, Nguyen TD, Stoddart JF, Zink JI. Supramolecular nanovalves controlled by proton abstraction and competitive binding. Chemistry of Materials 2006;18:5919-28. (Pubitemid 46084785)
107. Nguyen TD, Leung KCF, Liong M, Pentecost CD, Stoddart JF, Zink JI. Construction of a pH-driven supramolecular nanovalve. Organic Letters 2006;8:3363-6. (Pubitemid 44191962)
108. Xu WJ, Gao Q, Xu Y, Wu D, Sun YH. pH-controlled drug release from mesoporous silica tablets coated with hydroxypropyl methylcellulose phthalate. Materials Research Bulletin 2009;44:606-12.
109. Song SW, Hidajat K, Kawi S. pH-controllable drug release using hydrogel encapsulated mesoporous silica. Chemical Communications 2007:4396-8. (Pubitemid 351223606)
110. Zhu YF, Shi JL, Shen WH, Dong XP, Feng JW, Ruan ML, et al. Stimuliresponsive controlled drug release from a hollow mesoporous silica sphere/ polyelectrolyte multilayer core-shell structure. Angewandte Chemie International Edition 2005;44:5083-7.
111. Casasus R, Marcos MD, Martinez-Manez R, Ros-Lis JV, Soto J, Villaescusa LA, et al. Toward the development of Ionically controlled Nanoscopic molecular gates. Journal of the American Chemical Society 2004;126:8612-3. (Pubitemid 38955700)
112. Zheng HQ, Wang Y, Che SN. Coordination bonding-based mesoporous silica for pH-responsive anticancer drug doxorubicin delivery. Journal of Physical Chemistry C 2011;115:16803-13.
113. Kim HJ, Matsuda H, Zhou HS, Honma I. Ultrasound-triggered smart drug release from a poly(dimethylsiloxane)-mesoporous silica composite. Advanced Materials 2006;18. 3083-+.
114. Ferris DP, Zhao YL, Khashab NM, Khatib HA, Stoddart JF, Zink JI. Light-operated mechanized nanoparticles. Journal of the American Chemical Society 2009;131. 1686-+.
115. Knezevic NZ, Trewyn BG, Lin VSY. Functionalized mesoporous silica nanoparticle-based visible light responsive controlled release delivery system. Chemical Communications 2011;47:2817-9.
116. Mal NK, Fujiwara M, Tanaka Y. Photocontrolled reversible release of guest molecules from coumarin-modified mesoporous silica. Nature 2003;421: 350-3. (Pubitemid 36157928)
117. Lu J, Choi E, Tamanoi F, Zink JI. Light-activated nanoimpeller-controlled drug release in cancer cells. Small 2008;4:421-6. (Pubitemid 351641616)
118. Ruiz-Hernandez E, Baeza A, Vallet-Regi M. Smart drug delivery through DNA/magnetic nanoparticle gates. ACS Nano 2011;5:1259-66.
119. Kong SD, Zhang WZ, Lee JH, Brammer K, Lal R, Karin M, et al. Magnetically vectored nanocapsules for tumor penetration and remotely switchable on-demand drug release. Nano Letters 2010;10:5088-92.
120. Ruiz-Hernandez E, Lopez-Noriega A, Arcos D, Izquierdo-Barba I, Terasaki O, Vallet-Regi M. Aerosol-assisted synthesis of magnetic mesoporous silica spheres for drug targeting. Chemistry of Materials 2007;19:3455-63. (Pubitemid 47155024)
121. Ruiz-Hernandez E, Lopez-Noriega A, Arcos D, Vallet-Regi M. Mesoporous magnetic microspheres for drug targeting. Solid State Sciences 2008;10: 421-6.
122. Lopez-Noriega A, Ruiz-Hernandez E, Stevens SM, Arcos D, Anderson MW, Terasaki O, et al. Mesoporous microspheres with Doubly ordered core-shell structure. Chemistry of Materials 2009;21:18-20.
123. Arruebo M, Galan M, Navascues N, Tellez C, Marquina C, Ibarra MR, et al. Development of magnetic nanostructured silica-based materials as potential vectors for drug-delivery applications. Chemistry of Materials 2006;18: 1911-9.
124. Baeza A, Guisasola E, Ruiz-Hernández E, Vallet-Regí M. Magnetically triggered multidrug release by hybrid mesoporous silica nanoparticles. Chemistry of Materials 2012;24:517-24.
125. Liu R, Zhao X, Wu T, Feng PY. Tunable redox-responsive hybrid nanogated ensembles. Journal of the American Chemical Society 2008;130. 14418-+.
126. Hernandez R, Tseng H-R, Wong JW, Stoddart JF, Zink JI. An operational supramolecular nanovalve. Journal of the American Chemical Society 2004; 126:3370-1. (Pubitemid 38372118)
127. Nguyen TD, Tseng HR, Celestre PC, Flood AH, Liu Y, Stoddart JF, et al. A reversible molecular valve. Proceedings of the National Academy of Sciences, USA 2005;102:10029-34. (Pubitemid 41023320)
128. Nguyen TD, Liu Y, Saha S, Leung KCF, Stoddart JF, Zink JI. Design and optimization of molecular nanovalves based on redox-switchable bistable rotaxanes. Journal of the American Chemical Society 2007;129: 626-34. (Pubitemid 46147763)
129. Torney F, Trewyn BG, Lin VSY, Wang K. Mesoporous silica nanoparticles deliver DNA and chemicals into plants. Nature Nanotechnology 2007;2: 295-300. (Pubitemid 46882970)
130. Gruenhagen JA, Lai CY, Radu DR, Lin VSY, Yeung ES. Real-time imaging of tunable adenosine 5-triphosphate release from an MCM-41-type mesoporous silica nanosphere-based delivery system. Applied Spectroscopy 2005;59:424-31. (Pubitemid 40538308)
131. Porta F, Lamers GEM, Zink JI, Kros A. Peptide modified mesoporous silica nanocontainers. Physical Chemistry Chemical Physics 2011;13:9982-5.
132. Bernardos A, Mondragon L, Aznar E, Marcos MD, Martinez-Manez R, Sancenon F, et al. Enzyme-responsive intracellular controlled release using nanometric silica mesoporous supports capped with "Saccharides". ACS Nano 2010;4:6353-68.
133. Schlossbauer A, Kecht J, Bein T. Biotin-avidin as a protease-responsive cap system for controlled guest release from colloidal mesoporous silica. Angewandte Chemie International Edition 2009;48:3092-5.
134. Climent E, Bernardos A, Martinez-Manez R, Maquieira A, Marcos MD, Pastor-Navarro N, et al. Controlled delivery systems using antibody-capped mesoporous nanocontainers. Journal of the American Chemical Society 2009;131: 14075-80.
135. Prokop A, Davidson JM. Nanovehicular intracellular delivery systems. Journal of Pharmaceutical Sciences 2008;97:3518-90.
136. Schroeder A, Heller DA, Winslow MM, Dahlman JE, Pratt GW, Langer R, et al. Treating metastatic cancer with nanotechnology. Nature Reviews Cancer 2012;12:39-50.
137. Low PS, Kularatne SA. Folate-targeted therapeutic and imaging agents for cancer. Current Opinion in Chemical Biology 2009;13:256-62.
138. Rosenholm JM, Meinander A, Peuhu E, Niemi R, Eriksson JE, Sahlgren C, et al. Targeting of porous hybrid silica nanoparticles to cancer cells. ACS Nano 2009;3:197-206.
139. Liong M, Lu J, Kovochich M, Xia T, Ruehm SG, Nel AE, et al. Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. ACS Nano 2008;2:889-96.
140. Tsai CP, Chen CY, Hung Y, Chang FH, Mou CY. Monoclonal antibody-functionalized mesoporous silica nanoparticles (MSN) for selective targeting breast cancer cells. Journal of Materials Chemistry 2009;19: 5737-43.
141. Mamaeva V, Rosenholm JM, Bate-Eya LT, Bergman L, Peuhu E, Duchanoy A, et al. Mesoporous silica nanoparticles as drug delivery systems for targeted inhibition of notch signaling in cancer. Molecular Therapy 2011;19: 1538-46.
142. Rosenholm JM, Sahlgren C, Linden M. Multifunctional mesoporous silica nanoparticles for combined therapeutic, diagnostic and targeted action in cancer treatment. Curr Drug Targets 2011;12:1166-86.
143. Wu SH, Hung Y, Mou CY. Mesoporous silica nanoparticles as nanocarriers. Chemical Communications 2011;47:9972-85.
144. He QJ, Shi JL. Mesoporous silica nanoparticle based nano drug delivery systems: synthesis, controlled drug release and delivery, pharmacokinetics and biocompatibility. Journal of Materials Chemistry 2011;21: 5845-55.
145. Park IY, Kim IY, Yoo MK, Choi YJ, Cho MH, Cho CS. Mannosylated polyethylenimine coupled mesoporous silica nanoparticles for receptor-mediated gene delivery. International Journal of Pharmacognosy 2008;359:280-7.
146. Brevet D, Gary-Bobo M, Raehm L, Richeter S, Hocine O, Amro K, et al. Mannose-targeted mesoporous silica nanoparticles for photodynamic therapy. Chemical Communications 2009:1475-7.
147. Zhu CL, Lu CH, Song XY, Yang HH, Wang XR. Bioresponsive controlled release using mesoporous silica nanoparticles capped with aptamer-based molecular gate. Journal of the American Chemical Society 2011;133:1278-81.